IMC Chicago’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
92,800
+29,900
+48% +$579K ﹤0.01% 2561
2025
Q4
$1.35M Sell
62,900
-25,400
-29% -$535K ﹤0.01% 2748
2025
Q3
$1.7M Sell
88,300
-3,400
-4% -$60.6K ﹤0.01% 2343
2025
Q2
$1.57M Buy
91,700
+54,000
+143% +$2.3M ﹤0.01% 2183
2025
Q1
$2.41M Buy
37,700
+25,300
+204% +$2.66M ﹤0.01% 1680
2024
Q4
$1.51M Buy
+12,400
New +$1.52M ﹤0.01% 2075
2024
Q3
Sell
-21,100
Closed -$3.33M 3029
2024
Q2
$3.33M Buy
+21,100
New +$2.71M ﹤0.01% 1265
2024
Q1
Sell
-21,300
Closed -$2.05M 2494
2023
Q4
$2.05M Sell
21,300
-2,100
-9% -$201K ﹤0.01% 1203
2023
Q3
$2.84M Buy
23,400
+2,600
+13% +$294K ﹤0.01% 894
2023
Q2
$2.38M Sell
20,800
-58,700
-74% -$7.57M ﹤0.01% 833
2023
Q1
$11M Buy
79,500
+34,100
+75% +$4.42M 0.01% 465
2022
Q4
$5.88M Buy
45,400
+12,000
+36% +$1.39M 0.01% 566
2022
Q3
$3.69M Buy
+33,400
New +$3.37M ﹤0.01% 622
2022
Q1
Sell
-25,600
Closed -$2.31M 1244
2021
Q4
$2.31M Buy
25,600
+300
+1% +$25.6K ﹤0.01% 781
2021
Q3
$2.34M Sell
25,300
-15,900
-39% -$1.22M ﹤0.01% 809
2021
Q2
$3.2M Sell
41,200
-58,700
-59% -$4.45M ﹤0.01% 674
2021
Q1
$7.45M Buy
99,900
+62,800
+169% +$5.79M 0.01% 489
2020
Q4
$6.33M Sell
37,100
-6,000
-14% -$889K 0.01% 500
2020
Q3
$6.05M Buy
43,100
+19,900
+86% +$3.02M 0.01% 388
2020
Q2
$3.72M Buy
23,200
+3,700
+19% +$504K 0.01% 424
2020
Q1
$1.91M Sell
19,500
-29,200
-60% -$3.34M ﹤0.01% 510
2019
Q4
$6.28M Buy
48,700
+20,000
+70% +$2.02M 0.02% 303
2019
Q3
$2.16M Sell
28,700
-15,300
-35% -$1.81M 0.01% 447
2019
Q2
$6.69M Sell
44,000
-1,100
-2% -$134K 0.02% 237
2019
Q1
$5.38M Buy
+45,100
New +$5.8M 0.02% 230

Other funds holding SRPT